Jean-Francois Morineau
Operationeel Directeur bij BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
Profiel
Jean-Francois Morineau has worked as a Director at Egle Therapeutics SAS and as a Chief Operating Officer at BNP Paribas Real Estate Conseil Habitation & Hospitality SAS from 2011 to present.
Actieve functies van Jean-Francois Morineau
| Bedrijven | Functie | Begin |
|---|---|---|
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
 BNP Paribas Real Estate Conseil Habitation & Hospitality SAS Real Estate DevelopmentFinance Part of BNP Paribas SA, BNP Paribas Real Estate Conseil Habitation & Hospitality SAS operates as a real estate agency. The company is based in Issy-Les-Moulineaux, France. | Operationeel Directeur | 11-05-2011 |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS Real Estate DevelopmentFinance Part of BNP Paribas SA, BNP Paribas Real Estate Conseil Habitation & Hospitality SAS operates as a real estate agency. The company is based in Issy-Les-Moulineaux, France. | Finance |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Commercial Services |
